Stroke Trial, Recruiting (NCT06847256)

Stroke Trial, Recruiting NCT06847256 Sponsor: University of Iowa Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06847256 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have previously had genetic testing that identified them as a cystic fibrosis (CF) carrier or as someone without the CF gene change (a control)
People who are comfortable speaking and reading English

Who may not be able to join:

People who have previously had genetic testing that identified them as having cystic fibrosis (CF) themselves
People who have been diagnosed with Type 1 or Type 2 diabetes
People with a history of heart attack, stroke, heart failure, or a condition involving a buildup of fatty deposits in the arteries (atherosclerosis)
People who are currently pregnant
People who are currently taking beta blockers (a type of heart or blood pressure medication) or diuretics (water tablets)
People who are currently incarcerated (in prison)
People who are not able to sign and provide their own written consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aaron Miller, PhD, University of Iowa

Phone: (319) 335-3053

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06847256

Sponsor: University of Iowa

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: (319) 335-3053

More information: https://clinicaltrials.gov/study/NCT06847256

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have previously had genetic testing that identified them as a cystic fibrosis (CF) carrier or as someone without the CF gene change (a control)
People who are comfortable speaking and reading English

Who may not be able to join:

People who have previously had genetic testing that identified them as having cystic fibrosis (CF) themselves
People who have been diagnosed with Type 1 or Type 2 diabetes
People with a history of heart attack, stroke, heart failure, or a condition involving a buildup of fatty deposits in the arteries (atherosclerosis)
People who are currently pregnant
People who are currently taking beta blockers (a type of heart or blood pressure medication) or diuretics (water tablets)
People who are currently incarcerated (in prison)
People who are not able to sign and provide their own written consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Iowa

Registry

ClinicalTrials.gov

Start date

19 November 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Participant Scores for Temperature Sensitivity and Regulation Survey; Change in Weight; Change in Sodium Concentration; Change in Potassium Concentration; Concentration of Sweat Chloride; Final Score on Comfort Scale; Final Score on Thermosensation Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov